Your browser doesn't support javascript.
loading
SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
Steven J. Clipman; Amy Wesolowski; Shruti H. Mehta; Smisha Agarwal; Sarah E. Cobey; Derek A.T. Cummings; Dustin G. Gibson; Alain B. Labrique; Gregory D. Kirk; Sunil S. Solomon.
Afiliação
  • Steven J. Clipman; Johns Hopkins Bloomberg School of Public Health
  • Amy Wesolowski; Johns Hopkins Bloomberg School of Public Health
  • Shruti H. Mehta; Johns Hopkins Bloomberg School of Public Health
  • Smisha Agarwal; Johns Hopkins Bloomberg School of Public Health
  • Sarah E. Cobey; University of Chicago
  • Derek A.T. Cummings; University of Florida
  • Dustin G. Gibson; Johns Hopkins Bloomberg School of Public Health
  • Alain B. Labrique; Johns Hopkins Bloomberg School of Public Health
  • Gregory D. Kirk; Johns Hopkins University School of Medicine
  • Sunil S. Solomon; Johns Hopkins University School of Medicine
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20248789
ABSTRACT
ObjectiveTo characterize the SARS-CoV-2 testing cascade and associated barriers in three US states. MethodsWe recruited participants from Florida, Illinois, and Maryland ([~]1000/state) for an online survey September 16 - October 15, 2020. The survey covered demographics, COVID-19 symptoms, and experiences around SARS-CoV-2 PCR testing in the prior 2 weeks. Logistic regression was used to analyze associations with outcomes of interest. ResultsOverall, 316 (10%) of 3,058 respondents wanted/needed a test in the two weeks prior to the survey. Of these, 166 (53%) were able to get tested and 156 (94%) received results; 53% waited [≥] 8 days to get results from when they wanted/needed a test. There were no significant differences by state. Among those wanting/needing a test, getting tested was significantly less common among men (aOR 0.46) and those reporting black race (aOR 0.53) and more common in those reporting recent travel (aOR 3.35). ConclusionsThere is an urgent need for a national communication strategy on who should get tested and where one can get tested. Additionally, measures need to be taken to improve access and reduce turn-around-time.
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo observacional / Pesquisa qualitativa Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo observacional / Pesquisa qualitativa Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...